Inducible nitric oxide synthase depresses cardiac contractile function in Zucker diabetic fatty rats

European Journal of Pharmacology

Volumn 579, Issue 1-3, 2008, Pages 253-259

  Song, Dongzhe ^a   Kuo, Kuo Hsing ^a,b   Yao, Reina ^a   Hutchings, Simon R ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

Author keywords

Cardiac function; Diabetes; Dobutamine; iNOS

Indexed keywords

3 NITROTYROSINE; DOBUTAMINE; HALOTHANE; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE;

ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MODEL; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART RATE; ILIAC ARTERY; ILIAC VEIN; IMMUNOHISTOCHEMISTRY; INTRAVENOUS CATHETER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ZUCKER DIABETIC FATTY RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MYOCARDIAL CONTRACTION; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, ZUCKER; VENTRICULAR FUNCTION, LEFT;

EID: 37549053729     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.043     Document Type: Article

References (39)

1. Bell D.S. Diabetic cardiomyopathy. Diabetes Care 26 (2003) 2949-2951
2. Carmo A., Cunha-Vaz J.G., Carvalho A.P., and Lopes M.C. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide 4 (2000) 590-596
3. Ceriello A., Quagliaro L., Catone B., Pascon R., Piazzola M., Bais B., Marra G., Tonutti L., Taboga C., and Motz E. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 25 (2002) 1439-1443
4. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., and Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51 (2002) 1076-1082
5. Chatham J.C., and Seymour A.M. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc. Res. 55 (2002) 104-112
6. Cheng X., and Pang C.C.Y. Increased vasoconstriction to noradrenaline by 1400 W, inhibitor of iNOS, in rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 484 (2004) 263-268
7. Cheng X., Leung S.W.S., Lo L.S., and Pang C.C.Y. Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia. N.-S. Arch. Pharmacol. 367 (2003) 372-379
8. Cheng X., Cheng X.S., Kuo K.H., and Pang C.C.Y. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes. Cardiovasc. Res. 64 (2004) 298-307
9. Dai S., and McNeill J.H. Myocardial performance of STZ-diabetic DOCA-hypertensive rats. Am. J. Physiol. 263 (1992) H1798-H1805
10. Dowell R.T., Atkins F.L., and Love S. Integrative nature and time course of cardiovascular alterations in the diabetic rat. J. Cardiovasc. Pharmacol. 8 (1986) 406-413
11. Ellis E.A., Guberski D.L., Hutson B., and Grant M.B. Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 6 (2002) 295-304
12. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 138 (2003) 532-543
13. Fredersdorf S., Thumann C., Ulucan C., Griese D.P., Luchner A., Riegger G.A., Kromer E.P., and Weil J. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc. Pathol. 13 (2004) 11-19
14. Ganguly P.K., Pierce G.N., Dhalla K.S., and Dhalla N.S. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am. J. Physiol. 244 (1983) E528-E535
15. Gealekman O., Abassi Z., Rubinstein I., Winaver J., and Binah O. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation 105 (2002) 236-243
16. Golfman L., Dixon I.M., Takeda N., Chapman D., and Dhalla N.S. Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes. Mol. Cell. Biochem. 200 (1999) 15-25
17. Hare J.M., Loh E., Creager M.A., and Colucci W.S. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92 (1995) 2198-2203
18. Heyliger C.E., Pierce G.N., Singal P.K., Beamish R.E., and Dhalla N.S. Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res. Cardiol. 77 (1982) 610-618
19. Joe E.K., Schussheim A.E., Longrois D., Maki T., Kelly R.A., Smith T.W., and Balligand J.L. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J. Mol. Cell. Cardiol. 30 (1998) 303-315
20. Kannel W.B., Hjortland M., and Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am. J. Cardiol. 34 (1974) 29-34
21. Kumaramanickavel G., Sripriya S., Vellanki R.N., Upadyay N.K., Badrinath S.S., Rajendran V., Sukumar B., Ramprasad V.L., and Sharma T. Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients. Clin. Genet. 61 (2002) 344-348
22. Litwin S.E., Raya T.E., Anderson P.G., Daugherty S., and Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J. Clin. Invest. 86 (1990) 481-488
23. Liu X., Takeda N., and Dhalla N.S. Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim. Biophys. Acta 1316 (1996) 78-84
24. Liu X., Takeda N., and Dhalla N.S. Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats. Metabolism 46 (1997) 71-75
25. Malhotra A., Penpargkul S., Fein F.S., Sonnenblick E.H., and Scheuer J. The effect of streptozotocin-induced diabetes in rats on cardiac contractile proteins. Circ. Res. 49 (1981) 1243-1250
26. Matsuda N., Hattori Y., Gando S., Akaishi Y., Kemmotsu O., and Kanno M. Diabetes-induced down-regulation of beta1-adrenoceptor mRNA expression in rat heart. Biochem. Pharmacol. 58 (1999) 881-885
27. Morris B.J., Markus A., Glenn C.L., Adams D.J., Colagiuri S., and Wang L. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J. Mol. Med. 80 (2002) 96-104
28. Nagareddy P.R., Xia Z., McNeill J.H., and MacLeod K.M. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am. J. Physiol, Heart Circ. Physiol. 289 (2005) H2144-H2152
29. Okayama H., Hamada M., and Hiwada K. Contractile dysfunction in the diabetic-rat heart is an intrinsic abnormality of the cardiac myocyte. Clin. Sci. (Lond.) 86 (1994) 257-262
30. Schulz R., Dodge K.L., Lopaschuk G.D., and Clanachan A.S. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am. J. Physiol. 272 (1997) H1212-H1219
31. Seftel A.D., Vaziri N.D., Ni Z., Razmjouei K., Fogarty J., Hampel N., Polak J., Wang R.Z., Ferguson K., Block C., and Haas C. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 50 (1997) 1016-1026
32. Shimabukuro M., Ohneda M., Lee Y., and Unger R.H. Role of nitric oxide in obesity-induced beta cell disease. J. Clin. Invest. 100 (1997) 290-295
33. Stuehr D.J., and Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169 (1989) 1543-1555
34. Tannous M., Rabini R.A., Vignini A., Moretti N., Fumelli P., Zielinski B., Mazzanti L., and Mutus B. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 42 (1999) 539-544
35. Ungureanu-Longrois D., Balligand J.L., Kelly R.A., and Smith T.W. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J. Mol. Cell. Cardiol. 27 (1995) 155-167
36. Wang M.Y., Koyama K., Shimabukuro M., Newgard C.B., and Unger R.H. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 714-718
37. Wu F., Cepinskas G., Wilson J.X., and Tyml K. Nitric oxide attenuates but superoxide enhances iNOS expression in endotoxin- and IFNgamma-stimulated skeletal muscle endothelial cells. Microcirculation 8 (2001) 415-425
38. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., and Unger R.H. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1784-1789
39. 2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51 (2002) 198-203